Analytical Data
-
基因名
frxA
- Application
-
别名
frxA; Protein FrxA
-
种属
Others
-
表达系统
E. coli
-
标签
Tag Free
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q51795
-
表达区间
M1-E137
-
蛋白长度
Full Length
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FrxA (ferritin-like protein A) is a key protein involved in iron metabolism and homeostasis in various organisms. Its study is crucial due to the role of iron in essential biological processes, including oxygen transport, DNA synthesis, and electron transport. Dysregulation of iron homeostasis can lead to several health issues, such as anemia, neurodegenerative diseases, and other metabolic disorders. In recent years, researchers have focused on the recombinant expression of FrxA to better understand its structure and function. By producing FrxA as a recombinant protein in host systems like E. coli or yeast, scientists can obtain large quantities of the protein for biochemical assays, structural studies, and functional analyses. These studies aim to elucidate FrxA's mechanisms of iron binding and release, as well as its interactions with other cellular components. Additionally, understanding FrxA's role may contribute to the development of therapeutic strategies for iron-related diseases. As the demand for efficient iron metabolism becomes increasingly important in various biomedical contexts, the research on FrxA recombinant protein represents a significant advancement in the field of molecular biology and medical research.












